Combination Ruxolitinib and Selinexor for the Treatment of Naïve Myelofibrosis

Video

Srdan Verstovsek, MD, reviews data presented at ASH 2022 on combination ruxolitinib and selinexor for the frontline treatment of myelofibrosis.

Related Videos
Related Content